FIELD: medicine.
SUBSTANCE: group of inventions relates to medicine, namely to infectious diseases and can be used for obtaining medication for treatment and prevention of hepatitis C. Claimed is application of sangliferin, binding with cyclophilin, of formula 
in obtaining medication for treatment and prevention of hepatitis C and associated with it diseases, inhibition of hepatitis C virus replication, prevention of hepatitis C recurrence.
EFFECT: application of inventions makes it possible to extend arsenal of means for prevention and treatment of hepatitis C.
3 cl
| Title | Year | Author | Number |
|---|---|---|---|
| APPLICATION OF MODIFIED CYCLOSPORINS FOR TREATING HCV INDUCED DISEASES | 2004 |
|
RU2389501C2 |
| USE OF MODIFIED CYCLOSPORINES | 2007 |
|
RU2463071C2 |
| PREDICTION OF KINETICS OF HEPATITIS C VIRUS IN INTERFERON-EXCLUDING TREATMENT | 2011 |
|
RU2590691C2 |
| HEPATITIS C VIRUS INHIBITORS | 2010 |
|
RU2544010C2 |
| APPLICATION OF MEDICATIONS, BINDING EDG-RECEPTOR, IN TREATMENT OF CANCER DISEASE | 2008 |
|
RU2426555C2 |
| APPLICATION OF EDG-RECEPTOR BINDING AGENT IN CANCER THERAPY | 2003 |
|
RU2358717C2 |
| PANGENOTYPIC NS5A PROTEIN INHIBITOR OF HEPATITIS C VIRUS, A PHARMACEUTICAL COMPOSITION AND METHODS FOR PREPARING AND USING | 2019 |
|
RU2723482C1 |
| USE OF CYTOKINE OF INTERLEUKIN-6 FAMILY FOR MAKING COMPOSITION FOR JOINT ADMINISTRATION WITH INTERFERON-ALPHA | 2006 |
|
RU2413529C2 |
| PHARMACEUTICAL COMPOSITION | 2004 |
|
RU2355418C2 |
| CYCLOSPORIN ANALOGS MOLECULES MODIFIED BY 1 AND 3 AMINO ACIDS | 2011 |
|
RU2630690C9 |
